Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-28

FDA Approved: LOW-OGESTREL — Supplemental Application (Mayne Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Low-Ogestrel, a combined oral contraceptive containing norgestrel and ethinyl estradiol, from Mayne Pharma, auth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOW-OGESTREL (NORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for LOW-OGESTREL (NORGESTREL AND ETHINYL ESTRADIOL)